Immunoediting, the loss of tumor (neo)antigens due to T cell-dependent selection, sculpts tumor immunoge-nicity. In Nature, Luksza et al. conceive a model to score neoantigens??? immunogenicity and predict tumor clonal evolution. With this model, they demonstrate that durable tumor control associates with selective limited acquisition of high-quality mutations.
展开▼
